Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma
Postoperative platinum-based multiagent chemotherapy was associated with improved disease-free survival. These findings provide crucial information for shared decision-making regarding whether to undergo adjuvant chemotherapy.
Authors
- Ken D Yamaguchi (ORCID: https://orcid.org/0000-0002-7669-1405)
- Yukiko Taga (ORCID: https://orcid.org/0009-0000-8468-6350)
- Kota Yamauchi (ORCID: https://orcid.org/0000-0003-1454-6103)
- Yoshihide Inayama (ORCID: https://orcid.org/0000-0003-2040-5913)
- Yukio Yamanishi (ORCID: https://orcid.org/0009-0005-5010-9228)
- Naoki Horikawa (ORCID: https://orcid.org/0000-0001-8480-6420)
- Takahito Ashihara (ORCID: https://orcid.org/0000-0003-1500-4488)
- Masaki Mandai (ORCID: https://orcid.org/0000-0003-4428-8029)
- Yukako Mizuno
- Ikuko Emoto (ORCID: https://orcid.org/0000-0003-1427-2675)
- Maki Umemiya
- Motonori Matsubara
- Kazuki Yamano (ORCID: https://orcid.org/0000-0001-5723-7584)
- Saya Kiyoshige
- Miki Otsuki
- Kenzo Kosaka
Institutions
- Twitter (United States) (US)
- National Confidential Enquiry into Patient Outcome and Death (GB)
- Shizuoka Red Cross Hospital (JP)
Publication Details
- Journal
- O&G Open
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/og9.0000000000000031
- Citations
- 3
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.07